Skip to main content
Fig. 10 | Journal of Ovarian Research

Fig. 10

From: A methylation- and immune-related lncRNA signature to predict ovarian cancer outcome and uncover mechanisms of chemoresistance

Fig. 10

FTO increases the drug sensitivity of ovarian cancer cells to cDDP and PPAR inhibitors. Cell Edu assay (Scale bar: 200 μm) (A) and Tunel staining experiment (Scale bar: 200 μm) (B) of A2780 cells transfected with si-FTO were shown. Cell Viability (left panels) and IC50 (right panels) for cDDP (C) and PPAR inhibitor (D) in A2780 cells transfected with si-FTO. *p < 0.05, **p < 0.01, ***p < 0.001

Back to article page